No Detail Found!

Neimann-pick diseases: beyond lipid accumulation - genetic, diagnostics, and therapeutic strategies

Author(s)
Hind M Naffadi Department of Medical Genetics, faculty of medicine, Umm Al-Qura University, Makkah , Saudi Arabia
Abstract
Rare genetic disorders are the group of disorders/diseases that occur in such a low count that they are not considered much active market for therapeutics unless encouraged by appropriate incentives and support. They are too rare to be fully investigated and managed by health professionals. Genetic disorders are caused by change in genes and are often serious and complex. Around the world, most affected individuals are found to be children. They can be progressive and might get worse as children grow older. Niemann-Pick diseases (NPD) is one such group of rare genetic diseases that are characterized by unwanted and abnormal accumulation of lipids within the cells. In this review, we discuss the history, genetic basis, clinical manifestations and diagnostic approaches for NPD. We further discuss the pathophysiology of accumulation of lipids and their impact on cellular functions and organ systems and various management strategies.
Publication Details
Page(s) 703-713
DOI DOI not available
Published Journal: Advancements in life sciences, Volume: 11, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Genetic mutation, Lipid metabolism, rare disease, Cholesterol trafficking, Neurological abnormalities
References
Vanier MT .2013 .Niemann-pick diseases. The Handbook of Clinical Neurology, 113 : 1717-1721.
Kolodny EH .2000 .Niemann-Pick disease. Current Opinion in Hematology, 7(1) : 48-52.
Percival BC,Gibson M,Wilson PB,Platt FM,Grootveld M. .2020 .Metabolomic studies of lipid storage disorders, with special reference to Niemann-Pick type C disease: A critical review with future perspectives. International Journal of Molecular Sciences, 21(7) : 2533.
Rodrigues KF,Yong WTL,Bhuiyan MSA,Siddiquee S,Shah MD .2022 .Current understanding on the genetic basis of key metabolic disorders: a review. Biology, 11(9) : 1308.
Vitiello L,De Bernardo M,Nuzio SG,Mandato C,Rosa N,Vajro P .2020 .Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other. Digestive and liver disease, 52(1) : 1-8.
Toledano-Zaragoza A,Ledesma MD .2020 .Addressing neurodegeneration in lysosomal storage disorders: Advances in Niemann Pick diseases. , 171 : 107851.
Schuchman EH,Desnick RJ .2017 .Types a and B Niemann-pick disease. Molecular Genetics and Metabolism, 120(1- 2) : 27-33.
Pfrieger FW .2023 .The Niemann-Pick type diseases-A synopsis of inborn errors in sphingolipid and cholesterol metabolism. Progress in Lipid Research, 90 : 101225.
Vanier .2010 .. Orphanet Journal of Rare Diseases, : 1-18.
Guatibonza Moreno P,Pardo LM,Pereira C,Schroeder S,Vagiri D .2023 .At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over 15 years. European Journal of Human Genetics, 31(10) : 1108-1116.
Hendriksz CJ,Anheim M,Bauer P,Bonnot O,Chakrapani A .2017 .The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease. Current Medical Research and Opinion, 33(5) : 877-890.
Patterson M.,Niemann-Pick disease M. .2020 .. , : 1993-2024.
McGovern MM,Avetisyan R,Sanson B-J .2017 .Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD). Current Medical Research and Opinion, 12(1) : 1-13.
Pinto C,Sousa D,Ghilas V,Dardis A,Scarpa M .2021 .and Macedo MF Acid sphingomyelinase deficiency: a clinical and immunological perspective. International Journal of Molecular Sciences, 22(23) : 12870.
Zampieri S,Filocamo M,Pianta A,Lualdi S,Gort L,Coll MJ,Sinnott R,Geberhiwot T,Bembi B,Dardis A .2016 .SMPD1 mutation update: database and comprehensive analysis of published and novel variants. Human Mutation, 37(2) : 139-147.
Deshpande D,Gupta SK,Sarma AS,Ranganath P,Jain S JMN .2021 .Functional characterization of novel variants in SMPD1 in Indian patients with acid sphingomyelinase deficiency. Human Mutation, 42(10) : 1336-1350.
. .Infantile spasms in early-onset Niemann-Pick disease with a novel compound heterozygous mutations in SMPD1 gene. , : .
Elsevier .2015 .. , 2(6) : 155-158.
Mukherjee SB,Pandey M,Kapoor S .2012 .Infant with type A Niemann Pick disease and undetectable Niemann Pick cells in bone marrow. Indian Pediatrics, 49(6) : 490.
Reddy JV,Ganley IG .2006 .Clues to neurodegeneration in Niemann-Pick type C disease from global gene expression profiling. PLoS One, 1(1) : e19.
.2021 .. International Journal of Molecular Sciences, 22(16) : 8858.
Bulut FD,Bozbulut NE,Özalp Ö,Dalgiç B,Mungan NÖ .2022 .Diagnostic value of plasma lysosphingolipids levels in a Niemann-Pick disease type C patient with transient neonatal cholestasis. Journal of Pediatric Endocrinology and Metabolism, 35(5) : 681-685.
Newton J,Palladino EN,Weigel C,Maceyka M,Gräler MH .2020 .Targeting defective sphingosine kinase 1 in NiemannPick type C disease with an activator mitigates cholesterol accumulation. Journal of Biological Chemistry, 295(27) : 9121-9133.
.2023 .Childhood dementia: A collective clinical approach to advance therapeutic development and care. Pediatric Neurology, 139 : 76-85.
Cariati I,Masuelli L,Bei R,Tancredi V,Frank C,D'Arcangelo G. .2021 .Neurodegeneration in niemann-pick type c disease: An updated review on pharmacological and nonpharmacological approaches to counteract brain and cognitive impairment. International Journal of Molecular Sciences, 22(12) : 6600.
Marchetti M,Faggiano S .2022 .Mozzarelli A. Enzyme replacement therapy for genetic disorders associated with enzyme deficiency. Current Medicinal Chemistry, 29(3) : 489-525.
Garside B,Ho JH,Kwok S,Liu Y,Dhage S . .Changes in PCSK 9 and apolipoprotein B100 in Niemann-Pick disease after enzyme replacement therapy with olipudase alfa. , : .
.2021 .. Orphanet Journal of Rare Diseases, 27(1) : 107.
Ryckman AE,Brockhausen I .2020 .Walia, JS. Metabolism of glycosphingolipids and their role in the pathophysiology of lysosomal storage disorders. nternational Journal of Molecular Sciences, 21(18) : 6881.
Zakir F,Mohapatra S,Farooq U,Mirza MA,Iqbal Z .2022 .. Drug Delivery Systems for Metabolic Disorders, : 1-20.
.2023 .Childhood dementia: A collective clinical approach to advance therapeutic development and care. Pediatric Neurology, 139 : 76-85.
Kannan P,Nanda Kumar MP,Rathinam N,Kumar DT,Ramasamy M. Elucidating .2023 .the mutational impact in causing Niemann-Pick disease type C: an in silico approach. Journal of Biomolecular Structure and Dynamics, 41(17) : 8561-8570.
Dardis A,Zampieri S,Gellera C,Carrozzo R,Cattarossi S .2020 .Molecular genetics of Niemann-Pick Type C disease in Italy: an update on 105 patients and description of 18 NPC1 novel variants. Journal of Clinical Medicine, 9(3) : 679.
Xu Y,Zhang Q,Tan L,Xie X,Zhao Y. .2019 .The characteristics and biological significance of NPC2: Mutation and disease. Mutation Research - Reviews in Mutation Research, 782 : 108284.
Metcalfe SA .2018 .Genetic counselling, patient education, and informed decision-making in the genomic era. Seminars in Fetal and Neonatal Medicine, 23(2) : 142-149.
Kumar K,Cowley M,Wetterstrand K,Watson J,Crick F,Sanger F,Nicklen S .2019 .Next-generation sequencing and emerging technologies. in Seminars in thrombosis and hemostasis. , : .
Sudrié-Arnaud B,Snanoudj S,Dabaj I,Dranguet H,AbilyDonval L H .2021 .Next-Generation Molecular Investigations in Lysosomal Diseases: Clinical Integration of a Comprehensive Targeted Panel. , 11(2) : 294.
Guan C,Gan X,Yang C,Yi M,Zhang Y .2022 .Wholeexome sequencing analysis to identify novel potential pathogenetic NPC1 mutations in two Chinese families with Niemann-Pick disease type C. Neurological Sciences, (. , 43(6) : 3957-3966.
Brain Metabolic,Disease Metabolic .2019 .. , 34(5) : 1253-1260.
Hu J,Maegawa GH,Zhan X,Gao X,Wang Y .2021 .Clinical, biochemical, and genotype‐phenotype correlations of 118 patients with Niemann‐Pick disease Types A/B. , 42(5) : 614-625.
Cooper J,Church H,Wu HY .2020 .-triol: further insights into the performance of this oxysterol in diagnosis of Niemann-Pick disease type C. Molecular Genetics and Metabolism, (. , 130(1) : 77-86.
.2023 .Investigation of Brain Iron in Niemann-Pick Type C: A 7T Quantitative Susceptibility Mapping Study. Journal of Neuroradiology, 44(7) : 768-775.
.2019 .Proteomics of the corpus callosum to identify novel factors involved in hypomyelinated Niemann-Pick Type C disease mice. Molecular Brain, 12(1) : 1-11.
Amin MM .2019 .(. IGI Global, : 195-216.
.2020 .Clinical and preclinical imaging of hepatosplenic schistosomiasis. , 36(2) : 206-226.
Neurology Current .2020 .. , 20(11) : 51.
Genes .1990 .. , 14(11) : .
.2022 .Genetic disease and Niemann-Pick disorders: novel treatments and drug delivery systems. Drug Delivery Systems for Metabolic Disorders, : 161-175.
Pineda M,Walterfang M,Patterson MC .2018 .Miglustat in Niemann-Pick disease type C patients: a review. Orphanet Journal of Rare Diseases, 13(1) : 1-21.
Bonnot O,Klünemann H-H,Velten C,Martin JVT,Walterfang M. .2019 .Systematic review of psychiatric signs in Niemann-Pick disease type C. The World Journal of Biological Psychiatry, 20(4) : 320-332.
Rego T,Farrand S,Goh AM,Eratne D,Kelso W .2019 .Psychiatric and cognitive symptoms associated with Niemann-Pick type C disease: neurobiology and management. CNS Drugs, 33(2) : 125-142.
Li M. .2018 .Enzyme replacement therapy: a review and its role in treating lysosomal storage diseases. Pediatric Annals, 47(5) : e191-e197.
Marchetti M,Faggiano S .2022 .Mozzarelli A. Enzyme replacement therapy for genetic disorders associated with enzyme deficiency. Current Medicinal Chemistry, 29(3) : 489-525.
Jones SA,McGovern M,Lidove O,Giugliani R,Mistry PK .2020 .Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy. Molecular Genetics and Metabolism, 131(1-2) : 116-123.
Del Grosso A,Parlanti G,Mezzena R,Cecchini M. .2022 .Current treatment options and novel nanotechnologydriven enzyme replacement strategies for lysosomal storage disorders. Advanced Drug Delivery Reviews, : 114464.
Yue WW,Mackinnon S .2019 .Substrate reduction therapy for inborn errors of metabolism. Emerging Topics in Life Sciences, 3(1) : 63-73.
Höller A,Albrecht U,Sigl SB,Zöggeler T,Ramoser G .2021 .Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C. Molecular genetics and metabolism reports. , 27 : 100723.
Samaranch L,Pérez-Cañamás A,Soto-Huelin B,Sudhakar V,Jurado-Arjona J,Science Translational Medicine .2019 .Adeno-associated viral vector serotype 9-based gene therapy for NiemannPick disease type A. , 11(506) : eaat3738.
Massaro G,Geard AF,Liu W,Coombe-Tennant O,Waddington SN,Baruteau J,Gissen P,Rahim AA .2021 .Gene therapy for lysosomal storage disorders: ongoing studies and clinical development. Biomolecules, 11(4) : 611.
Jiang D,Lee H .2020 .Pardridge WM. Plasmid DNA gene therapy of the Niemann-Pick C1 mouse with transferrin receptor-targeted Trojan horse liposomes. Scientific Reports, 10(1) : 13334.
Tran ML,Génisson Y,Ballereau S .2020 .Second-generation pharmacological chaperones: beyond inhibitors. Molecules, 25(14) : 3145.
Du J,Liu X,Zhang Y,Han X,Ma C .2022 .The Effects of Combined Therapy With Metformin and Hydroxypropyl-β- Cyclodextrin in a Mouse Model of Niemann-Pick Disease Type C1. , 12 : 825425.
Holzmann C,Witt M,Rolfs A,Antipova V .2021 .Wree A. Gender-specific effects of two treatment strategies in a mouse model of niemann-pick disease type c1. International Journal of Molecular Sciences, 22(5) : 2539.
Kurokawa Y,Osaka H,Kouga T,Jimbo E,Muramatsu K .2021 .Gene therapy in a mouse model of niemann-pick disease type C1. Human Gene Therapy, (. , 32 : 589-598.
Deodato F,Boenzi S,Taurisano R,Semeraro M,Sacchetti E .2018 .The impact of biomarkers analysis in the diagnosis of Niemann-Pick C disease and acid sphingomyelinase deficiency. Clinica Chimica Acta, 486 : 387-394.
Jiang X,Ory D. X .2021 .Advancing diagnosis and treatment of Niemann-Pick C disease through biomarker discovery. Exploration of Neuroprotective Therapy, 1(3) : 146.
Sobrido M-J P,De Koning T,Klopstock T,Nadjar Y,Patterson MC,Synofzik M,Hendriksz CJ .2019 .Recommendations for patient screening in ultra-rare inherited metabolic diseases: what have we learned from Niemann-Pick disease type C? Orphanet Journal of Rare Diseases, (. , 14(1) : 1-14.
Mengel E,Bembi B,Del Toro M,Deodato F,Gautschi M .2020 .Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study. Orphanet Journal of Rare Diseases, 15(1) : 1-18.
Seaby EG .2020 .Ennis S. Challenges in the diagnosis and discovery of rare genetic disorders using contemporary sequencing technologies. Briefings in Functional Genomics, 19(4) : 243-258.
Hammerschmidt TG,Ribas G.,Saraiva-Pereira ML,Bonatto MP,Kessler RG .2018 .Molecular and biochemical biomarkers for diagnosis and therapy monitorization of Niemann-Pick type C patients. International Journal of Developmental Neuroscience, 66 : 18-23.
Walterfang M,Di Biase MA,Cropley VL,Scott AM,O'Keefe G,Velakoulis D,Pathmaraj K,Ackermann U .2020 .Imaging of neuroinflammation in adult Niemann-Pick type C disease: A cross-sectional study. Neurology, 94(16) : e1716-e1725.
Eskes EC,Sjouke B,Vaz FM,Goorden SM,Van Kuilenburg AB .2020 .Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers. Molecular Genetics and Metabolism, 130(1) : 16-26.
Hammerschmidt TG,Encarnação M,Faverzani JL,de Fátima JL,de Oliveira FP .2023 .Molecular profile and peripheral markers of neurodegeneration in patients with Niemann-Pick type C: Decrease in Plasminogen Activator Inhibitor type 1 and Platelet-Derived Growth Factor type AA. Archives of Biochemistry and Biophysics, 735 : 109510.
Vujosevic S,Parra MM,Hartnett ME,O'Toole L,Nuzzi A,Limoli C,Villani E,Nucci P .2023 .Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children. Eye (Lond), 37(2) : 203-219.
Bolukbasi S,Dogan C,Kiykim E,Cakir A,Erden B .2019 .Multimodal imaging including optical coherence tomography angiography in patients with type B NiemannPick disease. International ophthalmology, 39 : 2545-2552.
Verheul C,Kleijn A .2018 .Cerebrospinal fluid biomarkers of malignancies located in the central nervous system. Handbook of Clinical Neurology, 146 : 139-169.
Campbell K,Cawley NX,Luke R,Scott KE,Johnson N .2023 .Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1. Biomarker Research, 11(1) : 14.
Agrawal N,Farhat NY,Sinaii N,Do AD,Xiao C .2023 .Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1. , 25(3) : 100349.
De Castro-Oros I,Irún P,Cebolla JJ,Rodriguez-Sureda V,Mallén M .2017 .Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study. Journal of Translational Medicine, 15(1) : 43.
Degtyareva AV,Proshlyakova TY,Gautier MS,Degtyarev DN,Kamenets EA .2019 .Oxysterol/chitotriosidase based selective screening for Niemann-Pick type C in infantile cholestasis syndrome patients. BMC Medical Genetics, 20(1) : 123.
Papandreou A,Doykov I,Spiewak J,Komarov N,Habermann S .2022 .Niemann-Pick type C disease as proof‐of‐concept for intelligent biomarker panel selection in neurometabolic disorders. Developmental Medicine & Child Neurology, 64(12) : 1539-1546.
.2019 .Diagnostic performance evaluation of sulfate-conjugated cholesterol metabolites as urinary biomarkers of NiemannPick disease type C. Clinica Chimica Acta, (. , 494 : 58-63.
. .To read the copy of this license please visit: https://creativecommons. , : .
0

Citations

0

Downloads

65

Views